HCA
RPTX

Harbor Capital Advisors’s Repare Therapeutics RPTX Stock Holding History

Harbor Capital Advisors’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,659
Closed -$286K – 763
2024
Q1 		$286K Buy
60,659
+12,604
+26% +$80.7K 0.04% 531
2023
Q4 		$351K Buy
48,055
+5,970
+14% +$33.4K 0.07% 295
2023
Q3 		$508K Buy
42,085
+5,101
+14% +$52.6K 0.11% 226
2023
Q2 		$391K Buy
36,984
+3,370
+10% +$34.7K 0.08% 288
2023
Q1 		$331K Sell
33,614
-958
-3% -$11K 0.1% 176
2022
Q4 		$509K Buy
+34,572
New +$517K 0.49% 62

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harbor Capital Advisors's RPTX Position: Q2 2024 in Review

Harbor Capital Advisors sold out of Repare Therapeutics (RPTX) in Q2 2024, closing a stake of 60,659 shares — an estimated $286K sold.

Harbor Capital Advisors first reported a position in RPTX in Q4 2022 and held it in 6 quarters. The position peaked at $509K in Q4 2022. 61 funds tracked by Wall St. Rank hold RPTX as of Q2 2024.

  • Harbor Capital Advisors reported no remaining Repare Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 60,659 Repare Therapeutics shares in Q2 2024, an estimated $286K.
  • Harbor Capital Advisors first reported a position in Repare Therapeutics in Q4 2022 and held it in 6 quarters.
  • Harbor Capital Advisors's Repare Therapeutics position peaked at $509K in Q4 2022.
  • 61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2024.

Based on Harbor Capital Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.